Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTF2I antisense RNA 1 (GTF2I-AS1)
- Target
- GTF2I-AS1
- Molecular classification
- Antisense long non-coding RNA (AS-lncRNA), Non-coding RNA (ncRNA)
01
Overview
GTF2I antisense RNA 1 (GTF2I-AS1) is a non-coding RNA gene that produces an antisense transcript overlapping the GTF2I locus. Like other antisense long non-coding RNAs (AS-lncRNAs), it may regulate gene expression through transcriptional interference, alteration of chromatin structure, or by interacting with regulatory proteins; however, specific functional studies or disease associations for GTF2I-AS1 are currently undocumented in the major literature and databases. This distinguishes it from its sense counterpart, GTF2I, which encodes a well-characterized transcription factor involved in transcriptional regulation and disease. Research on antisense RNAs as a class suggests diverse regulatory roles but information specific to GTF2I-AS1 remains lacking[3][6][9]. If more specific or updated research emerges on the function or therapeutic relevance of GTF2I-AS1, these fields can be further filled out.
- Other names
- GTF2I-AS1
02
Biological functions
Regulation of gene expression (including transcriptional interference and modulation of chromatin structure)Potential cis- and trans-regulatory functions over neighboring and distant genes through RNA-RNA, RNA-DNA, or RNA-protein interactions
03
Disease associations
Other (no well-established direct involvement in specific diseases, but by analogy to other antisense lncRNAs, may be implicated in disease contexts through regulation of its sense gene, GTF2I)
Beyond the preview
Go deeper on GTF2I antisense RNA 1 (GTF2I-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GTF2I antisense RNA 1 (GTF2I-AS1).